Tiberias

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease2 trials
• Chronic lymphocytic leukaemia2 trials
• Heart failure1 trial
• High blood pressure1 trial
• Lupus (SLE)1 trial

Phase

• Phase 35 trials

Status

• Active, not recruiting3 trials
• Recruiting2 trials
• Not yet recruiting1 trial

Lead sponsor

• AstraZeneca4 trials
• Acerta Pharma BV2 trials

Running trials

• Recruiting

  A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  NCT07753993· Phase 3· AstraZeneca· Source

• Recruiting

  A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  NCT06742723· Phase 3· AstraZeneca· Source

• Recruiting

  Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

  NCT06307652· Phase 3· AstraZeneca· Source

• Active, not recruiting

  A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice.

  NCT05637112· AstraZeneca· Source

• Active, not recruiting

  Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Participants With High Risk Chronic Lymphocytic Leukemia (CLL)

  NCT02477696· Phase 3· Acerta Pharma BV· Source

• Active, not recruiting

  Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL

  NCT02475681· Phase 3· Acerta Pharma BV· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease2 recruiting
• Heart failure1 recruiting
• High blood pressure1 recruiting